Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS

PURPOSE: Several patients with advanced cancer suffer from breakthrough cancer pain (BTcP). BTcP is pain exacerbation despite opioid baseline therapy. Fentanyl buccal tablet (FBT) is a rapid-onset opioid for the treatment of BTcP. The aim of this study is to document the feasibility of FBT in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Masel, Eva Katharina, Landthaler, Robert, Gneist, Margit, Watzke, Herbert Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752740/
https://www.ncbi.nlm.nih.gov/pubmed/28849261
http://dx.doi.org/10.1007/s00520-017-3853-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752740/
https://www.ncbi.nlm.nih.gov/pubmed/28849261
http://dx.doi.org/10.1007/s00520-017-3853-y

Ejemplares similares